Contraceptive Technology Update 2014-06 - Contraceptive Technology Update - Jun 01, 2014

Target Audience:

This activity is intended for OB/GYNs, nurses, nurse practitioners, and other family planners.

Accreditation:

AHC Media is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation:

This activity has been approved for 1.25 nursing contact hours using a 60-minute contact hour.

Provider approved by the California Board of Registered Nursing, Provider # 14749, for 1.25 Contact Hours.

Nurses licensed in California should retain this credit letter for four years.

Faculty Listing:

Consulting Editor
Andrew M. Kaunitz, MD
Professor and Associate Chairman
Department of OB/GYN
University of Florida College of Medicine
Jacksonville

Authors
Rebecca Bowers

Executive Editor
Joy Dickinson
AHC Media

Nurse Reviewer
Melanie Deal, MS, WHNP-BC, FNP
Nurse Practitioner
San Francisco State University Student Health Services
San Francisco

Subjects:

  • Retention of patients is critical to family planning financial sustainability
  • Check digital trends in STI prevention
  • Accelerate HPV vaccine uptake: Time to move
  • Diaphragm: Update on this barrier contraceptive
  • Teratogenic drug use: Check contraception
  • Quick Start: Why put off what you can do today?

Objectives:

  • Identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive services
  • Describe how those issues affect services and patient care
  • Integrate practical solutions to problems and information into daily practices, according to advice from nationally recognized family planning experts
  • Provide practical information that is evidence-based to help clinicians deliver contraceptives sensitively and effectively

Financial Disclosure:

Consulting Editor Andrew M. Kaunitz, MD, discloses that he is a retained consultant for Actavis, Teva Pharmaceutical Industries Ltd., Merck, and Bayer; he receives grant/research support from Bayer, Trimel, and TherapeuticsMD; and he receives royalties from UpToDate. Author Rebecca Bowers, and Executive Editor Joy Dickinson report no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study. Melanie Deal, nurse reviewer, discloses that she is on the speakers bureau for Actavis and Merck & Co. and the advisory board for Actavis, Teva, and Hologic. Melanie Gold, guest columnist, reports that she is on the speaker’s bureau for Novartis. Anita Brakman, guest columnist, has no relevant relationships to disclose.

Copyright 2014, AHC Media. All rights reserved.